SCHEMBL7946473

SCHEMBL7946473

N#Cc1c(C(F)(F)F)c(-c2cccnc2)n2c1CCCC2

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 4/20 0.43
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HTT P42858 2/20 0.40
GAA P10253 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
TSHR P16473 1/20 0.40
CYP11B2 P19099 3/20 0.39
PTGS2 P35354 4/20 0.38
RECQL P46063 1/20 0.38
ADORA1 P30542 2/20 0.36
CYP11B1 P15538 1/20 0.36
MAOA P21397 1/20 0.36
ABCG2 Q9UNQ0 3/20 0.36
ADORA2A P29274 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7587234 0.85 ABCC1 (0.44) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7954850 0.83 ABCC1 (0.43) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7953813 0.82 ABCC1 (0.43) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL2158205 0.82 KDM4E (0.45) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7590017 0.82 CYP11B2 (0.44) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7953497 0.81 CYP11B2 (0.42) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7953612 0.79 ABCC1 (0.41) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7955035 0.79 ABCC1 (0.43) ABCC1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7961681 0.78 CYP11B2 (0.37) ALDH1A1KDM4EGAAAPOBEC3GCYP11B2
SCHEMBL7954913 0.76 ABCC1 (0.41) ABCC1ALDH1A1KDM4EHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP disclosed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO disclosed